Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the seven analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $17.3750.
AFYA has been the subject of a number of recent analyst reports. UBS Group reiterated a “neutral” rating and set a $16.00 price target (down from $18.00) on shares of Afya in a report on Friday. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a report on Wednesday, October 8th. Zacks Research cut Afya from a “hold” rating to a “strong sell” rating in a research report on Friday, January 9th. JPMorgan Chase & Co. restated a “neutral” rating and set a $22.00 target price (down previously from $24.50) on shares of Afya in a report on Wednesday, January 7th. Finally, Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research note on Friday.
Check Out Our Latest Analysis on AFYA
Institutional Inflows and Outflows
Afya Price Performance
Shares of NASDAQ:AFYA opened at $13.93 on Friday. The stock has a market cap of $1.31 billion, a P/E ratio of 10.02, a P/E/G ratio of 0.52 and a beta of 0.53. Afya has a 12 month low of $13.12 and a 12 month high of $19.90. The company has a 50 day moving average of $14.78 and a 200 day moving average of $15.02. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21.
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Recommended Stories
- Five stocks we like better than Afya
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
